CSPIA
CVS icon

Cary Street Partners Investment Advisory’s CVS Health CVS Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$696K Buy
6,725
+1,983
+42% +$177K 0.14% 155
2026
Q1 		$341K Buy
4,742
+80
+2% +$6.16K 0.09% 249
2025
Q4 		$370K Buy
4,662
+934
+25% +$73.6K 0.1% 206
2025
Q3 		$281K Buy
3,728
+266
+8% +$18.2K 0.12% 194
2025
Q2 		$239K Buy
3,462
+264
+8% +$17.3K 0.12% 196
2025
Q1 		$217K Buy
3,198
+510
+19% +$30.5K 0.12% 201
2024
Q4 		$121K Sell
2,688
-9,910
-79% -$556K 0.08% 244
2024
Q3 		$792K Sell
12,598
-4,256
-25% -$248K 0.03% 396
2024
Q2 		$995K Sell
16,854
-160,775
-91% -$10.1M 0.04% 347
2024
Q1 		$14.2M Buy
177,629
+3,283
+2% +$251K 0.6% 39
2023
Q4 		$13.8M Sell
174,346
-7,128
-4% -$507K 0.66% 32
2023
Q3 		$12.7M Buy
181,474
+74,233
+69% +$5.26M 0.68% 32
2023
Q2 		$7.41M Buy
107,241
+854
+0.8% +$60.8K 0.48% 53
2023
Q1 		$7.91M Sell
106,387
-1,332
-1% -$112K 0.57% 47
2022
Q4 		$10M Sell
107,719
-3,033
-3% -$293K 0.74% 42
2022
Q3 		$10.6M Buy
110,752
+9,496
+9% +$940K 0.87% 30
2022
Q2 		$9.38M Buy
101,256
+94,094
+1,314% +$9.18M 0.8% 32
2022
Q1 		$724K Buy
7,162
+2,399
+50% +$252K 0.2% 126
2021
Q4 		$491K Buy
4,763
+441
+10% +$40.8K 0.14% 155
2021
Q3 		$367K Buy
4,322
+324
+8% +$27.1K 0.12% 164
2021
Q2 		$334K Buy
3,998
+30
+0.8% +$2.46K 0.11% 178
2021
Q1 		$299K Sell
3,968
-8,155
-67% -$594K 0.12% 165
2020
Q4 		$828K Sell
12,123
-79,925
-87% -$5.2M 0.16% 134
2020
Q3 		$5.38M Buy
+92,048
New +$5.73M 1.14% 15

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cary Street Partners Investment Advisory's CVS Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its CVS Health (CVS) stake by 42% in Q2 2026, buying an estimated $177K and bringing the position to 6,725 shares worth $696K. The position accounts for 0.14% of the portfolio, ranked #155.

Cary Street Partners Investment Advisory first reported a position in CVS in Q3 2020 and has held it in 24 quarters since. The position peaked at $14.2M in Q1 2024. 1,469 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Cary Street Partners Investment Advisory held 6,725 shares of CVS Health worth $696K as of Q2 2026.
  • Cary Street Partners Investment Advisory bought 1,983 CVS Health shares in Q2 2026, an estimated $177K.
  • CVS Health made up 0.14% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #155 holding.
  • Cary Street Partners Investment Advisory first reported a position in CVS Health in Q3 2020 and has held it in 24 quarters since.
  • Cary Street Partners Investment Advisory's CVS Health position peaked at $14.2M in Q1 2024.
  • 1,469 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.